References
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983; 65: 55–63
- Carmichael J., Mitchell J. B., DeGraff W. G., Gamson J., Gazdar A. F., Johnson B. E., Glatstein E., Minna J. D. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. British Journal of Cancer 1985; 57: 540–7
- Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research 1987; 47: 936–42
- Campling B. G., Pym J., Galbraith P. R., Cole S. P. C. Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leukemia Research 1988; 1: 823–31
- Sargent J. M., Taylor C. G. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukemia. British Journal of Cancer 1989; 60: 206–10
- Veerman A. J. P., Pieters R. Drug sensitivity assays in leukemia and lymphoma. British Journal of Haematology 1990; 74: 381–4
- Keating M. J., Kantarjian H., Talpaz M., Redman J., Koller C., Barlogie B., Velasquez W., Plunkett W., Freireich E. J., McCredie K. B. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25
- Keating M. J., Kantarjian H., O'Brien S., Koller C., Talpaz M., Schachner J., Childs C. C., Freireich E. J., McCredie K. B. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology 1991; 9: 44–49
- Mandelli F., Gastaldi R., Monarca B., Coluzzi S., De Rossi G. Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL). European Journal of Haematology 1991; 46: 58–59
- Pini M., Foa R. Combined use of alpha 2b interferon and chlorambucil in the management of previously treated B-cell chronic lymphocytic leukemia. Leukemia and Lymphoma. 1991, in press
- Rozman C., Montserrat E., Vinolas N., Urbano-Ispizua A., Ribera J. M., Gallart T., Compernolle C. Recombinant α 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages. Blood 1988; 71: 1295–98
- Ziegler-Heitbrock H. W. L., Schlag R., Flieger D., Thiel E. Favorable response of early stage B-CLL patients to treatment with IFN-α2. Blood 1989; 73: 1426–30